BLRX
Income statement / Annual
Last year (2023), BioLineRx Ltd.'s total revenue was $4.80 M,
and the percentage change from the previous year is not available.
In 2023, BioLineRx Ltd.'s net income was -$60.61 M.
See BioLineRx Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$4.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3.69 M |
$654,000.00 |
$702,000.00 |
$934,000.00 |
$940,000.00 |
$451,000.00 |
$480,675.00 |
$481,888.00 |
$440,893.00 |
$0.00 |
| Gross Profit |
$1.11 M |
-$654,000.00 |
-$702,000.00 |
-$934,000.00 |
-$940,000.00 |
-$451,000.00 |
-$480,675.00 |
-$481,888.00 |
-$440,893.00 |
$0.00 |
| Gross Profit Ratio |
0.23 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$12.52 M
|
$17.63 M
|
$19.47 M
|
$18.17 M
|
$23.44 M
|
$19.81 M
|
$19.51 M
|
$11.18 M
|
$11.49 M
|
$10.90 M
|
| General & Administrative
Expenses |
$16.64 M
|
$5.07 M
|
$4.27 M
|
$3.84 M
|
$3.74 M
|
$4.41 M
|
$4.04 M
|
$3.95 M
|
$3.65 M
|
$3.49 M
|
| Selling & Marketing
Expenses |
$14.59 M
|
$6.46 M
|
$1.00 M
|
$840,000.00
|
$857,000.00
|
$1.36 M
|
$1.69 M
|
$1.35 M
|
$1.00 M
|
$1.46 M
|
| Selling, General &
Administrative Expenses |
$31.23 M
|
$11.53 M
|
$5.27 M
|
$4.68 M
|
$4.60 M
|
$5.77 M
|
$5.73 M
|
$5.31 M
|
$4.65 M
|
$4.95 M
|
| Other Expenses |
$7.05 M |
$5.67 M |
$42,000.00 |
$70,000.00 |
$78,000.00 |
$27,000.00 |
-$260,000.00 |
$7,000.00 |
$153,000.00 |
$2.81 M |
| Operating Expenses |
$50.80 M |
$29.16 M |
$24.78 M |
$22.93 M |
$28.11 M |
$25.61 M |
$25.24 M |
$16.51 M |
$16.20 M |
$15.85 M |
| Cost And Expenses |
$54.49 M |
$29.16 M |
$24.78 M |
$22.93 M |
$28.11 M |
$25.61 M |
$25.24 M |
$16.51 M |
$16.20 M |
$15.85 M |
| Interest Income |
$2.01 M |
$694,000.00 |
$559,000.00 |
$236,000.00 |
$777,000.00 |
$719,000.00 |
$1.17 M |
$480,000.00 |
$457,000.00 |
$3.28 M |
| Interest Expense |
$2.17 M |
$2.16 M |
$984,000.00 |
$1.47 M |
$1.83 M |
$21,000.00 |
$21,000.00 |
$14,000.00 |
$15,000.00 |
$411,666.00 |
| Depreciation &
Amortization |
$1.38 M
|
$654,000.00
|
$702,000.00
|
$934,000.00
|
$940,000.00
|
$451,000.00
|
$480,675.00
|
$481,888.00
|
$441,000.00
|
$246,537.00
|
| EBITDA |
-$57.06 M
|
-$28.50 M
|
-$25.35 M
|
-$21.99 M
|
-$27.17 M
|
-$25.15 M
|
-$23.83 M
|
-$15.34 M
|
-$13.94 M
|
-$10.79 M
|
| EBITDA Ratio |
-11.89 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
-10.35
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$10.92 M
|
$4.21 M
|
-$2.28 M
|
-$7.09 M
|
$2.67 M
|
$2.64 M
|
$888,000.00
|
$672,000.00
|
$1.80 M
|
$6.18 M
|
| Income Before Tax |
-$60.61 M |
-$24.95 M |
-$27.05 M |
-$30.02 M |
-$25.45 M |
-$22.96 M |
-$24.35 M |
-$15.84 M |
-$14.40 M |
-$10.17 M |
| Income Before Tax Ratio
|
-12.63
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$1,000.00 |
-$6.08 M |
$1.09 M |
$911,000.00 |
$1.36 M |
-$4.46 M |
-$888,000.00 |
-$672,000.00 |
-$1.80 M |
-$5.68 M |
| Net Income |
-$60.61 M |
-$18.87 M |
-$28.14 M |
-$30.93 M |
-$26.81 M |
-$18.51 M |
-$24.35 M |
-$15.84 M |
-$14.40 M |
-$10.17 M |
| Net Income Ratio |
-12.63 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.94 |
-0.37 |
-0.64 |
-1.84 |
-2.75 |
-2.56 |
-4.06 |
-4.23 |
-4.2 |
-4.71 |
| EPS Diluted |
-0.94 |
-0.37 |
-0.64 |
-1.84 |
-2.75 |
-2.56 |
-4.06 |
-4.23 |
-4.2 |
-4.71 |
| Weighted Average Shares
Out |
$64.22 M
|
$51.60 M
|
$44.20 M
|
$16.86 M
|
$9.76 M
|
$7.24 M
|
$6.00 M
|
$3.74 M
|
$3.43 M
|
$2.16 M
|
| Weighted Average Shares
Out Diluted |
$64.22 M
|
$51.60 M
|
$44.20 M
|
$16.86 M
|
$9.76 M
|
$7.24 M
|
$6.00 M
|
$3.74 M
|
$3.43 M
|
$2.16 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
